Work

HSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort study

Year: 2016

Type: article

Study design: Observational Study

Source: The Lancet Oncology

DOI: 10.1016/s1470-2045(16)30227-3

Authors: Jason W D Hearn, Ghada AbuAli, Chad A Reichard, Chandana A Reddy, Cristina Magi-Galluzzi, Kai-Hsiung Chang, Rachel Carlson, Laureano Rangel, Kevin Reagan, Brian J Davis, R Jeffrey Karnes, Manish Kohli, Donald Tindall, Eric A Klein, Nima Sharifi

Institutions: University of Michigan, Mayo Clinic, Cleveland Clinic

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: U.S. Department of Defense, Howard Hughes Medical Institute, American Cancer Society, Mayo Clinic, Prostate Cancer Foundation, Conquer Cancer Foundation, American Society of Clinical Oncology, Cleveland Clinic, Department of Radiation Oncology, UCLA Health System, National Institutes of Health, National Cancer Institute, Medical Research and Materiel Command, UNC Department of Radiation Oncology

Awards: G1724790107, G3698819184, Compensatory steroidogenesis mechanisms in castration-resistant prostate cancer, G4870427513, G7331610507, G8945760470, G9000140840, G9000141652

OpenAlex ID: W2514486754

FWCI: 15.08

Cites: 46

Cited by: 137

Related to: 10